The Health-Related Quality of Life of Chronic Hepatitis B Virus Carriers Admitted to Yalgado OUEDRAOGO University Hospital, from January 31 to May 31, 2022, Burkina Faso  

作　　者：Abdoul-Guaniyi Sawadogo Abdoul Rasmané Zongo Hamed Sidwaya Ouedraogo Ben Moctar Abdou Djibo Nadine Marie Stella Zombré Lawagoulé Joseph Emile Ky Arouna Sessouma Ramondegue Winde Alphonsine Inès Sawadogo Stella Line Emmanuella Pare Roger Sombié Abdoul-Guaniyi Sawadogo;Abdoul Rasmané Zongo;Hamed Sidwaya Ouedraogo;Ben Moctar Abdou Djibo;Nadine Marie Stella Zombré;Lawagoulé Joseph Emile Ky;Arouna Sessouma;Ramondegue Winde Alphonsine Inès Sawadogo;Stella Line Emmanuella Pare;Roger Sombié(Jhpiego Corporation, Ouagadougou, Burkina Faso;National Medical Council of Burkina Faso, Ouagadougou, Burkina Faso;Department of Hepatogastroenterology, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso;Ministry of Health, Directorate of Population Health Protection, Ouagadougou, Burkina Faso;Ministry of Health, District Hospital of Nongr Massom, Ouagadougou, Burkina Faso;Ministry of Health, Gaoua Regional Hospital, Gaoua, Burkina Faso;Health Sciences Training and Research Unit, Universit Joseph Ki-Zerbo, Ouagadougou, Burkina Faso)

机构地区：[1]Jhpiego Corporation, Ouagadougou, Burkina Faso [2]National Medical Council of Burkina Faso, Ouagadougou, Burkina Faso [3]Department of Hepatogastroenterology, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso [4]Ministry of Health, Directorate of Population Health Protection, Ouagadougou, Burkina Faso [5]Ministry of Health, District Hospital of Nongr Massom, Ouagadougou, Burkina Faso [6]Ministry of Health, Gaoua Regional Hospital, Gaoua, Burkina Faso [7]Health Sciences Training and Research Unit, Universit Joseph Ki-Zerbo, Ouagadougou, Burkina Faso

出　　处：《Advances in Infectious Diseases》2024年第4期737-757,共21页传染病进展(英文)

摘　　要：Introduction: According to the World Health Organization, chronic hepatitis B is the leading cause of mortality from liver disease and constitutes a public health problem. The aim of this study was to assess the quality of life of chronic hepatitis B virus carriers at the Yalgado OUEDRAOGO University hospital, and to identify the factors associated with this quality of life. Methods: We conducted a cross-sectional study at the Yalgado OUEDRAOGO University Hospital from January 31 to May 31, 2022, among chronic hepatitis B carriers aged at least 18 years who were followed for at least six months, treated or not. Results: The study included 135 patients, with an average age of 41.62 ± 10.69 years and a male predominance (64.44%). The average infection duration was 8.11 years ± 6, and the Chronic Liver Disease Questionnaire - Hepatitis B Virus (CLDQ-HBV) global quality of life score was 5.95 ± 0.90. Respondents’ overall quality of life was linked with gender, history of depression, and history of fatigue (ORa = 0.42 (p = 0.009), ORa = 1.57 (p Conclusion: Our study enabled us to assess mean quality of life scores according to the CLDQ-HBV dimensions, and to identify factors associated with the quality of life of chronic HBV carrier patients. Public health measures such as early diagnosis and management, and free care related to this infection would improve the quality of life of these patients.Introduction: According to the World Health Organization, chronic hepatitis B is the leading cause of mortality from liver disease and constitutes a public health problem. The aim of this study was to assess the quality of life of chronic hepatitis B virus carriers at the Yalgado OUEDRAOGO University hospital, and to identify the factors associated with this quality of life. Methods: We conducted a cross-sectional study at the Yalgado OUEDRAOGO University Hospital from January 31 to May 31, 2022, among chronic hepatitis B carriers aged at least 18 years who were followed for at least six months, treated or not. Results: The study included 135 patients, with an average age of 41.62 ± 10.69 years and a male predominance (64.44%). The average infection duration was 8.11 years ± 6, and the Chronic Liver Disease Questionnaire - Hepatitis B Virus (CLDQ-HBV) global quality of life score was 5.95 ± 0.90. Respondents’ overall quality of life was linked with gender, history of depression, and history of fatigue (ORa = 0.42 (p = 0.009), ORa = 1.57 (p Conclusion: Our study enabled us to assess mean quality of life scores according to the CLDQ-HBV dimensions, and to identify factors associated with the quality of life of chronic HBV carrier patients. Public health measures such as early diagnosis and management, and free care related to this infection would improve the quality of life of these patients.

关 键 词：Hepatitis B Virus Chronic Carrier Quality of Life CLDQ-HBV 

分 类 号：R57[医药卫生—消化系统]